Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Kenvue Inc. logo

NASDAQ · KVUE

Kenvue Inc.

Consumer Defensive · Household & Personal Products

$19.31

Down-$0.25 (-1.28%)

Updated Oct 31, 2026, 9:31 PM

SID Score

7.1/10

Composite research score

Smart Money

58/100

Neutral

Market cap
33.2B
P/E ratio
23.19
Dividend yield
4.28%
52-week range
$16.56 – $20.13
Volume
66.6M
Avg. volume
40.52M

Price performance · KVUE

KVUE price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

KVUE closed at $19.31 after 21 trading sessions, up 12.27% for the selected period.

Last close
$19.31
Period change
+12.27%
Period low
$17.20
Period high
$19.88
Daily close
View OHLC price history
KVUE OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$19.99$20.00$19.20$19.3166.6M
Oct 29, 2026$19.52$19.605$19.3344$19.5612.32M
Oct 28, 2026$19.31$19.48$19.25$19.3310.65M
Oct 27, 2026$19.43$19.44$19.265$19.4315.87M
Oct 26, 2026$19.51$19.75$19.40$19.509.54M
Oct 23, 2026$19.77$19.84$19.3834$19.5711.09M
Oct 22, 2026$19.18$19.89$19.17$19.8815.51M
Oct 21, 2026$19.23$19.28$19.015$19.0423.71M
Oct 20, 2026$18.97$19.30$18.95$19.2821.96M
Oct 19, 2026$18.70$18.92$18.665$18.8713.71M
Oct 16, 2026$18.74$18.945$18.715$18.9127.69M
Oct 15, 2026$18.38$18.77$18.38$18.6726.39M
Oct 14, 2026$17.92$18.035$17.76$18.0127.61M
Oct 13, 2026$17.91$17.94$17.54$17.7627.39M
Oct 12, 2026$17.66$17.83$17.485$17.8320.29M
Oct 9, 2026$17.70$17.80$17.63$17.7028.47M
Oct 8, 2026$17.58$17.74$17.44$17.7323.27M
Oct 7, 2026$17.62$17.69$17.52$17.5311.88M
Oct 6, 2026$17.46$17.645$17.41$17.5910.87M
Oct 5, 2026$17.24$17.405$17.165$17.3913.93M
Oct 2, 2026$17.33$17.38$17.1614$17.2014M

Latest KVUE news

The latest Smart Investors Daily articles mentioning KVUE.

Stock researchCompany · Overview

KVUE research

Overview

Company profile and research snapshot.

Company profile

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$18.57
Implied upside
—
Analysts
—
KVUE recent ratings
DateFirmRatingTarget
Aug 11, 2026UBSNeutral—
Jul 21, 2026BarclaysEqual-Weight—
Jul 16, 2026UBSNeutral—
Apr 15, 2026CitigroupNeutral—
Apr 14, 2026BarclaysEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 22, 2026

Global Teledermatology Market Size, Share, Trends, Growth and Forecast 2026-2035 | AI, Hybrid Care and DTC Models Fuel 14.10% CAGR to USD 60.96 Billion by 2035

Direct-to-consumer and hybrid models, AI-based personalisation, blockchain security, and mobile access are expanding convenient dermatology care in underserved areas.Dublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "Teledermatology Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)" has been added to ResearchAndMarkets.com's offering. The global teledermatology market was valued at USD 16.30 Billion in 2025 and is projected to grow at a CAGR of 14.10% from 2026 to 2

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By